These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5695578)

  • 21. Measles antibody in previously immunized children. The need for revaccination.
    Linnemann CC; Dine MS; Bloom JE; Schiff GM
    Am J Dis Child; 1972 Jul; 124(1):53-7. PubMed ID: 5033750
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles].
    Heidel G; Olbricht H; Ely K; Henkler J
    Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 24. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccination against measles in the Canadian Arctic.
    Furesz J; Habgood M
    JAMA; 1966 Jan; 195(5):342-4. PubMed ID: 5951890
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum titration of children vaccinated against measles].
    Morzycka M; Barteczkoi
    Pediatr Pol; 1968 Jul; 43(7):813-6. PubMed ID: 4174897
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic structure of the population characterizing measles susceptibility and its change with massive active immunization].
    Tsipershtein MIa; Shekhter AB
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):39-42. PubMed ID: 5037761
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
    Stehr K; Enders G; Suschke HJ; Spiess H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 30. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reactions of immunoglobulins and specific antibodies in vaccinated and nonvaccinated children with measles (author's transl].
    Wiedermannová D; Wiedermann D; Bozdĕchová M; Pejćochová J
    Cas Lek Cesk; 1977 Feb; 116(7):205-9. PubMed ID: 851980
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibody status following live measles vaccine--3 years postvaccination].
    Schumacher H; Welbers de Liddle IB
    Dtsch Med Wochenschr; 1970 Jul; 95(31):1594-8. PubMed ID: 5431984
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on measles in Thailand. V. Protection against a measles outbreak by previous vaccination in an isolated institution.
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S; Okuno Y
    Biken J; 1971 Dec; 14(4):413-7. PubMed ID: 5149999
    [No Abstract]   [Full Text] [Related]  

  • 35. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 37. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 38. Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.
    Norrby E; Lagercrantz R; Gard S; Carlström G
    Acta Paediatr Scand; 1965 Nov; 54(6):581-6. PubMed ID: 5832151
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 40. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.